Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 22;13:3411–3423. doi: 10.2147/OTT.S238665

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Ma et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Expression and clinical value of serum RNA-330-3p and PRRX1 in GC patients. (A) The expression of miR-330-3p was low while PRRX1 was high in the serum of GC patients. (B) The serum expression of miR-330-3p and PRRX1 presented a negative correlation in GC patients. (C) MiR-330-3p was lowly expressed while PRRX1 was highly expressed in GC tissues. (D) The positive rate of immunohistochemical detection of PRRX1 in GC tissues was significantly higher than in paracancerous tissues. (E) The AUC of miR-330-3p curve was 0.944, and that of the PRRX1 was 0.920.**Indicates P <0.05.